Milken Institute Future of Health Summit 2025 Explores Innovative and Impactful Ideas to Reimagine Health

Audio By Carbonatix

WASHINGTON--(BUSINESS WIRE)--Nov 4, 2025--

The Milken Institute 2025 Future of Health Summit opens today, convening leaders from business, health, and government to advance ideas that drive better health outcomes for all communities. Taking place November 4–6 at the Salamander Hotel in Washington, DC, the summit—centered on the theme “In Service of Better Health” —features sessions and discussions exploring the trends and innovations shaping the future of health.

Prominent government speakers include Jay Bhattacharya, Director, National Institutes of Health (NIH); Marty Makary, Commissioner, Food and Drug Administration (FDA); Mehmet Oz, Administrator, Centers for Medicare & Medicaid Services (CMS); Jim O’Neill, Deputy Secretary, US Department of Health and Human Services (HHS); and Dr.Meena Seshamani, Secretary, Maryland Department of Health.

They will be joined by Academy Award-Winning Actress and Advocate Lupita Nyong’o and former First Lady, Dr. Jill Biden, who will lead a conversation on “The Next Era of Women’s Health,” along with influential leaders such as Jeremy David, Head of US Healthcare, Palantir Technologies; Eric Lefkofsky, CEO of Tempus; Sharmila Makhija, Founding Dean and CEO, Alice L. Walton School of Medicine; and other changemakers committed to strengthening health systems, expanding access, and improving health worldwide.

“We’re at a turning point in health,” said Esther Krofah, EVP of Health at the Milken Institute. “Breakthroughs in science, technology, and data are redefining what’s possible, but progress only matters if it reaches people who need it most. The conversations here are designed to break down silos and accelerate real collaboration that turns innovation into impact. Better health should not be a privilege, but a promise.”

At the summit, updates will be shared on the Milken Institute’s multistakeholder efforts to advance solutions in biomedical innovation, public health, healthy aging, and food systems, including:

• Shaping the Future of US Biomedical Research and Innovation - The United States, a longtime global leader, sets the gold standard in scientific discoveries and regulatory review but now stands at a critical juncture. Other nations are investing heavily in their life sciences sectors, while fragmented systems, outdated processes, lack of coordination, and inconsistent investment threaten to slow America’s progress. FasterCures engaged leaders across the public, private, and philanthropic sectors to examine what it will take to preserve and strengthen US leadership in life sciences and to produce the advances needed to deliver more effective and affordable health care. This report presents a set of policy recommendations as a starting point for dialogue and action. From this foundation, leadership, cross-sector collaboration, and investment will be essential. The dividends will be clear: better health for all and a stronger, more secure future for the nation.

• Advancing Women’s Health – The Milken Institute Women’s Health Network is a global collaborative advancing research, innovation, and investment to improve women’s health. The network has expanded its membership to over 100 participating organizations and welcomed the American Cancer Society to its Steering Committee, reflecting broad collaboration across key sectors, including academia/research, advocacy, corporate/business, finance, health systems, pharma/life sciences, and technology.
  
  “ As we see cancer and other health challenges evolve for women, we have an unprecedented opportunity to address the future of women's health," said Shane Jacobson, CEO for the American Cancer Society. “I'm thrilled to join a distinguished group of leaders from the health care continuum uniting to drive meaningful change."
  
  Newly announced, the Women’s Health Network launched focused working groups and new initiatives to explore: investing to accelerate innovation and scale market access; regulatory solutions along the drug development life cycle for conditions that affect women exclusively, differentially, and/or differently; and considerations for payment and coverage of new products and technologies focused on women’s health conditions. Learn more at thewomenshealthnetwork.org.

Alongside the Future of Health Summit, the Milken Institute is releasing new research that elevates critical components of health and is tied to ongoing programmatic work:

• Effective yet Undervalued: Elevating Community Health Workers
• Employer Investments: Building Business, Employee, and Community Resilience
• The Evolving Role and Economic Impact of Employers in Communities
• The Future of US Biomedical Research and Innovation: Recommendations for Action
• Improving and Sustaining Health Through Prevention Across Medicare and Medicaid
• Longevity Ready: A Systems Approach to Aging Well at Home
• The Longevity Equation: How Healthspan and Wealthspan Intersect
• Opportunities for Local Mammography Deployment
• Schizophrenia Research and Care: Assessment of Challenges and Opportunities

With more than 50 sessions, the Summit will explore themes and recommendations emerging from these reports on critical health issues—from biomedical research and technological innovation to chronic disease and prevention, healthy aging and longevity, mental health, Food Is Medicine, women’s health, and more.

A robust lineup of summit panels offers a wide range of diverse topics, including: Innovating Hope: Charting the New Era of Alzheimer’s and Other Dementias, Charting the Course: Opportunities to Re-think Global Health, The Future of Science Funding, Reimagining Mental Health: Innovation at the Intersection of Care and Technology, Clear Vision and Bold Action: Funding Health Equity in a Changing America, Growing Up Unwell: Child, Youth and Adolescent Health in the United States, Biomedical Workforce in Crisis: What’s at Stake?, Innovations in Tech-Enabled Health Care, Integrating Food Into Health Care: What’s It Going to Take, and much more.

Upwards of 1,000 participants will attend the Future of Health Summit. Companies and organizations participating in the summit include AARP, Abbott, American Medical Association, Amazon, Amgen, Astrazeneca, Centene, City of Hope, Deloitte, Eli Lilly & Co, Guardant Health, IQVIA, Johnson & Johnson, Humana, Kroger, Mayo Clinic, Michael J. Fox Foundation, Microsoft, NYU Langone, OptumRx, Palantir, Samsung, Sanofi, Royalty Pharma, Siemens Healthineers, Tempus, and more.

The Milken Institute is live streaming the Future of Health Summit public sessions to expand access to the event. Explore the conference program and tune in to the live sessions.

For updates on the event, follow Milken Institute on Facebook, LinkedIn, X, and Instagram using #MIHealthSummit.

About the Milken Institute

The Milken Institute is a nonprofit, nonpartisan think tank focused on accelerating measurable progress on the path to a meaningful life. With a focus on financial, physical, mental, and environmental health, we bring together the best ideas and innovative resourcing to develop blueprints for tackling some of our most critical global issues through the lens of what’s pressing now and what’s coming next. For more information, visit www.milkeninstitute.org.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251104442135/en/

CONTACT: MEDIA CONTACT:

Chad Clinton

+1 (202) 262-1067

[email protected]

KEYWORD: DISTRICT OF COLUMBIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY HEALTH CONSUMER HEALTHCARE REFORM PUBLIC POLICY/GOVERNMENT PROFESSIONAL SERVICES OTHER PHILANTHROPY PHILANTHROPY THOUGHT LEADERSHIP RESEARCH GENERAL HEALTH FOUNDATION SCIENCE WOMEN

SOURCE: Milken Institute

Copyright Business Wire 2025.

PUB: 11/04/2025 10:57 AM/DISC: 11/04/2025 10:57 AM

http://www.businesswire.com/news/home/20251104442135/en